首页|内镜下不同比例聚桂醇泡沫硬化剂注射联合套扎术治疗Ⅱ~Ⅲ度内痔的临床效果

内镜下不同比例聚桂醇泡沫硬化剂注射联合套扎术治疗Ⅱ~Ⅲ度内痔的临床效果

扫码查看
目的 探讨不同比例的聚桂醇泡沫硬化剂注射联合套扎术治疗Ⅱ~Ⅲ度内痔的有效性及安全性.方法 选取2019年12月至2022年12月南宁市第一人民医院消化内科收治的90例内痔患者,按随机数表法将患者分为A、B、C三组.A组为聚桂醇原液组;B组为1∶1聚桂醇泡沫硬化剂组;C组为1∶2聚桂醇泡沫硬化剂组,每组各30例.对各组患者行硬化剂注射和套扎治疗.记录各组手术时间、聚桂醇用量、住院天数、术后疼痛、出血、疗效及异位栓塞、尿潴留、肛门感染等并发症情况.结果 三组手术时间、住院天数、并发症发生率比较,差异无统计学意义(P>0.05);三组手术费用、聚桂醇用量、术后疼痛、出血以及疗效比较,差异有统计学意义(P<0.05),其中B组和C组较A组手术费用和聚桂醇用量明显减少,术后疼痛和出血发生更低,疗效明显升高.但B组和C组手术费用、聚桂醇用量、术后疼痛和出血比较,差异无统计学意义(P>0.05).B组较C组临床疗效明显增高,差异有统计学意义(P<0.05).结论 内镜下1∶1的聚桂醇泡沫硬化注射治疗内痔具有效率高、用量少、费用低、术后出血少、疼痛轻以及并发症发生率低等特点,值得推广.
Clinical effect on the treatment of degree Ⅱ and Ⅲ internal hemorrhoids by injection of different proportions of lauromacrogol foam sclerosant combined with ligation under endoscope
Objective To explore the efficacy and safety of different proportions of lauromacrogol foam sclerosant combined with ligation in the treatment of degree Ⅱ and Ⅲ internal hemorrhoids.Methods A total of 90 patients with internal hemorrhoids admitted to the Department of Gastroenterology of the First People's Hospital of Nanning from December 2019 to December 2022 were selected and randomly divided into three groups:A,B and C.Group A was the lauromacrogol stock solution group,group B was the 1∶1 lauromacrogol foam sclerosant group,group C was the 1∶2 lauromacrogol foam sclerosant group,with 30 patients in each group.Patients in each group were treated with sclerosant injection and ligation.The operation time,dosage of lauromacrogol,length of stay,postoperative pain and bleeding,efficacy and complications such as ectopic embolism,urinary retention and anal infection were recorded in each group.Results There was no significant difference in operation time,length of stay,incidence of complications among the three groups(P>0.05).There were statistically significant differences in operation cost,dosage of lauromacrogol,postoperative pain and bleeding,and efficacy among the three groups(P<0.05).The operation cost and dosage of lauromacrogol of group B and C were significantly lower than those of group A,the postoperative pain and bleeding were lower,and the efficacy was significantly higher.However,there was no significant difference between group B and group C in operation cost,dosage of lauromacrogol,and postoperative pain and bleeding(P>0.05).The clinical efficacy of group B was significantly higher than that of group C,with statistically significant difference(P<0.05).Conclusion The injection of 1∶1 lauromacrogol foam sclerosant under endoscope for the treatment of internal hemorrhoids has the characteristics of high efficiency,low dosage,low cost,less postoperative bleeding,light pain and low incidence of complications,which is worth popularizing.

Internal hemorrhoidsLauromacrogol foam sclerosantDigestive endoscopyLigation

王家旭、覃屹、谢榕、罗期、唐少波、张伟伟

展开 >

南宁市第一人民医院消化内科,广西南宁 535000

内痔 聚桂醇泡沫硬化剂 消化内镜 套扎

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(14)